Investor
Phasechange
Nashville · United States
Phase Capital invests in US-based technology companies at the intersection of artificial intelligence, biology and proprietary data from pre-seed to Series A.
Stage
Pre-seed–Series A
Sectors
3 sectors
Cheque
Not confirmed
Invests in
United States
Sectors
About
This firm backs technology-first, revenue-generating companies. It focuses on the adaptive data layer of biotechnology, specifically platforms generating proprietary biological data. These investments form foundational infrastructure for future therapies, diagnostics, and industrial biology. The firm supports founders by providing access to downstream capital partners, strategics, and commercial relationships to accelerate impact. It organises the annual Frontiers Summit to convene stakeholders and strengthen the national technology-biology ecosystem.
How to approach
Contact the team regarding the fund or collaboration via the email address or contact form provided on their website.